Indonesia’s National Drug and Food Agency (BPOM) has given Emergency Use Authorization for the Sinovac COVID-19 vaccine.
In a press conference streamed online on Monday (Jan 11) BPOM said the Chinese-made vaccine has an efficacy rate of 65.3%, based on clinical trials in the Indonesian city of Bandung.
The vaccine, called Coronovac, was earlier passed as halal by Indonesia’s highest Islamic clerical body, MUI.
Continue reading
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Joined by 12,000+ Islamic economy professionals
Create a free account
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
